Oxford University researchers have unveiled a new blood test, powered by machine learning, which shows real promise in ...

Oxford Cancer Analytics (OXcan) has secured $11m in Series A funding for the development of its liquid biopsy blood tests for ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

Oxford University researchers have unveiled a new blood test, powered by machine learning, that shows promise in detecting ...

The Perlmutter Cancer Center at New York City-based NYU Langone Health recently launched its new Center for Molecular Oncology, naming Shridar Ganesan, MD, PhD, as director. The center will manage, ...

A groundbreaking study from the University of St Andrews School of Medicine has shown that biomarker testing in individuals ...

Ovarian cancer continues to claim thousands of lives in the UK each year, despite being relatively treatable if it’s caught early. However, an innovative laboratory test – the liquid biopsy – could ...

A study has demonstrated that biomarker testing in smokers and ex-smokers can reduce lung cancer deaths by 40%. This ...

The test – a so-called liquid biopsy – analyses DNA in the blood to detect subtle signs of cancer and could offer a fast and less invasive alternative to existing diagnostic tests. Professor ...

The term "liquid biopsy" is sometimes used to describe this ... The research team aims to explore how biomarker testing could ...

Oxford, UK and Toronto-based OXcan has secured over $11 million USD in Series A funding to develop and deploy its ...

Oxford Cancer Analytics Raises USD$11M in Series A Funding to Transform Early Lung Cancer Detection and Enable Curative Treatments ...